资金流向方面，主力资金净流入53.64万元，特大单买入164.85万元，占比2.99%，卖出121.95万元，占 比2.22%；大单买入1067.40万元，占比19.39%，卖出1056.66万元，占比19.19%。 三维化学今年以来股价涨23.62%，近5个交易日涨0.47%，近20日跌1.27%，近60日涨3.02%。 今年以来三维化学已经1次登上龙虎榜，最近一次登上龙虎榜为4月24日，当日龙虎榜净买入-3125.94万 元；买入总计1.81亿元 ，占总成交额比11.81%；卖出总计2.12亿元 ，占总成交额比13.85%。 资料显示，山东三维化学集团股份有限公司位于山东省淄博市临淄区炼厂中路22号，成立日期1994年11 月18日，上市日期2010年9月8日，公司主营业务涉及工程设计及工程总承包;催化剂的生产及销售。主 营业务收入构成为：醛醇酸酯类47.60%，工程总承包32.77%，残液加工类9.99%，催化剂销售4.80%， 工程设计3.68%，醋酸丁酸纤维素类0.77%，其他0.38%。 11月3日，三维化学盘中上涨2.16%，截至10:58，报8.53元/股，成交5505.59万元，换手率1.0 ...

Core Viewpoint - The financial performance and stock trading activity of Sanwei Chemical indicate a stable growth trajectory, with significant increases in revenue and net profit, while the financing and margin trading activities remain at relatively low levels [1][2][3]. Group 1: Financial Performance - For the first half of 2025, Sanwei Chemical achieved operating revenue of 1.249 billion yuan, representing a year-on-year growth of 21.81% [2]. - The net profit attributable to the parent company for the same period was 120 million yuan, showing a year-on-year increase of 42.54% [2]. - Cumulatively, the company has distributed a total of 1.291 billion yuan in dividends since its A-share listing, with 681 million yuan distributed over the past three years [3]. Group 2: Stock Trading Activity - On October 23, Sanwei Chemical's stock price increased by 0.22%, with a trading volume of 65.99 million yuan [1]. - The financing buy amount on the same day was 5.3262 million yuan, while the financing repayment was 6.1604 million yuan, resulting in a net financing buy of -834,200 yuan [1]. - As of October 23, the total balance of margin trading for Sanwei Chemical was 181 million yuan, which accounts for 3.10% of its market capitalization, indicating a low financing balance compared to the past year [1]. Group 3: Shareholder Information - As of June 30, the number of shareholders for Sanwei Chemical was 42,500, a decrease of 17.75% from the previous period [2]. - The average number of circulating shares per shareholder increased by 21.58% to 14,790 shares [2]. - Among the top ten circulating shareholders, Hongli Low Volatility (512890) is the second-largest shareholder with 27.8388 million shares, unchanged from the previous period [3].

Core Insights - The stock of Sanwei Chemical increased by 0.11% on September 30, with a trading volume of 61.93 million yuan [1] - The company reported a net financing outflow of 9.86 million yuan on the same day, with a total financing and securities balance of 215 million yuan [1] - Sanwei Chemical's revenue for the first half of 2025 reached 1.249 billion yuan, reflecting a year-on-year growth of 21.81%, while net profit attributable to shareholders was 120 million yuan, up 42.54% year-on-year [2] Financing and Margin Trading - On September 30, Sanwei Chemical had a financing buy amount of 5.55 million yuan, with a current financing balance of 215 million yuan, accounting for 3.78% of its market capitalization [1] - The financing balance is below the 20th percentile level over the past year, indicating a low position [1] - There were no short sales or repayments on the same day, with a short balance of 0 shares, also indicating a low position compared to the 40th percentile level over the past year [1] Shareholder and Dividend Information - As of June 30, the number of shareholders for Sanwei Chemical was 42,500, a decrease of 17.75% from the previous period, while the average circulating shares per person increased by 21.58% to 14,790 shares [2] - Since its A-share listing, Sanwei Chemical has distributed a total of 1.291 billion yuan in dividends, with 681 million yuan distributed in the last three years [3] - Among the top ten circulating shareholders, Hongli Low Volatility (512890) is the second-largest shareholder with 27.8388 million shares, unchanged from the previous period [3]

Core Viewpoint - The company, Sanwei Chemical, has shown positive financial performance with significant growth in revenue and net profit, alongside a stable shareholder structure and low financing levels [1][2][3]. Financial Performance - For the first half of 2025, Sanwei Chemical achieved a revenue of 1.249 billion yuan, representing a year-on-year growth of 21.81% [2]. - The net profit attributable to shareholders for the same period was 120 million yuan, reflecting a year-on-year increase of 42.54% [2]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Sanwei Chemical was 42,500, a decrease of 17.75% compared to the previous period [2]. - The average number of circulating shares per shareholder increased by 21.58% to 14,790 shares [2]. Financing and Margin Trading - On September 24, 2023, Sanwei Chemical recorded a financing buy-in of 15.134 million yuan, with a net buy of 3.6306 million yuan [1]. - The total financing and margin trading balance stood at 226 million yuan, accounting for 3.93% of the circulating market value, which is below the 30% percentile level over the past year [1]. Dividend Distribution - Since its A-share listing, Sanwei Chemical has distributed a total of 1.291 billion yuan in dividends, with 681 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, the second-largest circulating shareholder is Hongli Low Volatility Dividend (512890), holding 27.8388 million shares, unchanged from the previous period [3]. - The sixth-largest shareholder, CCB Low Volatility Dividend Index A (005561), reduced its holdings by 170,600 shares to 7.7373 million shares [3].